首页> 美国卫生研究院文献>American Journal of Physiology - Lung Cellular and Molecular Physiology >Translational Research in Acute Lung Injury and Pulmonary Fibrosis: Silencing Brutons tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury
【2h】

Translational Research in Acute Lung Injury and Pulmonary Fibrosis: Silencing Brutons tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury

机译:急性肺损伤和肺纤维化的转化研究:沉默肺泡中性粒细胞中的布鲁顿酪氨酸激酶可保护小鼠免受LPS /免疫复合物诱导的急性肺损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous observations made by our laboratory indicate that Bruton's tyrosine kinase (Btk) may play an important role in the pathophysiology of local inflammation in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). We have shown that there is cross talk between FcγRIIa and TLR4 in alveolar neutrophils from patients with ALI/ARDS and that Btk mediates the molecular cooperation between these two receptors. To study the function of Btk in vivo we have developed a unique two-hit model of ALI: LPS/immune complex (IC)-induced ALI. Furthermore, we conjugated F(ab)2 fragments of anti-neutrophil antibodies (Ly6G1A8) with specific siRNA for Btk to silence Btk specifically in alveolar neutrophils. It should be stressed that we are the first group to perform noninvasive transfections of neutrophils, both in vitro and in vivo. Importantly, our present findings indicate that silencing Btk in alveolar neutrophils has a dramatic protective effect in mice with LPS/IC-induced ALI, and that Btk regulates neutrophil survival and clearance of apoptotic neutrophils in this model. In conclusion, we put forward a hypothesis that Btk-targeted neutrophil specific therapy is a valid goal of research geared toward restoring homeostasis in lungs of patients with ALI/ARDS.
机译:我们实验室先前的观察表明,布鲁顿酪氨酸激酶(Btk)可能在急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)的局部炎症的病理生理中起重要作用。我们已经显示,来自ALI / ARDS患者的肺泡中性粒细胞中FcγRIIa和TLR4之间存在串扰,并且Btk介导这两个受体之间的分子协同作用。为了研究体内Btk的功能,我们已经开发了一种独特的ALI两次打击模型:LPS /免疫复合物(IC)诱导的ALI。此外,我们将抗中性粒细胞抗体(Ly6G1A8)的F(ab)2片段与Btk的特异性siRNA偶联,以使Btk在肺泡中性粒细胞中特异性沉默。应该强调的是,我们是第一个在体外和体内进行非嗜中性粒细胞转染的研究小组。重要的是,我们目前的发现表明,使肺泡中性粒细胞中的Btk沉默对LPS / IC诱导的ALI小鼠具有显着的保护作用,并且Btk在该模型中调节中性粒细胞的存活和凋亡性中性粒细胞的清除。总之,我们提出了一个假设,即针对Btk的中性粒细胞特异性疗法是针对恢复ALI / ARDS患者肺部稳态的有效研究目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号